%) and IPD (10%). This promising growth was due to more subspecialties, more Operation : Consolidated Profit & Loss Statement 2Q 2Q % 6 mth 6 mth % Unit : THB million 2019 2018 change 2019 2018 change

from July 2020 with a promising growth. 2 Profit/(Loss) After Taxation (“PAT”)/(“LAT”) 2.1 PAT/(LAT) for the 3-months ended 31 July 2020 INGRS registered loss after taxation of Baht 107.53 million for

) For the next financial year ending 31 January 2022 (“FY2021/22”), INGRS is looking for a promising improvement in automotive industry. In general, from the forecast released by automotive association

operations and is hopeful that appropriate measures will also be taken by the Government to support to support the Thailand Industries. 3. Performance of the Company Operating Results The Company reported a

% decrease. The promising growth of non-SW revenue was from IPD (49% growth) followed by OPD (14% growth) yoy. Both number of patients and revenue per head of 4Q19 increased. The higher revenue per head

%). This promising growth was due to more subspecialties as well as capacity expansion. OPD increased by 3 units and IPD increased by 17 units yoy. Number of OPD patients remained on the rise while revenue

net profit after deduction of NCI nevertheless increased by 11% yoy. This promising performance was mainly due to the increase of income coupled with wider gross margin as mentioned above. Page 3 of 4

the food and beverage business under brand Dean & DeLuca whereby the Company is promising to continue developing the projects. Please be informed accordingly. Yours sincerely, - Signed – (Mr. Sorapoj

% yoy. EBITDA margin rose from 26% of hospital revenue in 3Q18 to 28% in 3Q19. The promising EBITDA was attributable to not only the revenue growth but also the effective cost control as mentioned above

cost saving measures to minimize the negative impact of the COVID-19 pandemic on the Company’s future operations and is hopeful that appropriate measures will also be taken by the Government to support